Skip to main content
Premium Trial:

Request an Annual Quote

Involuntary Labmates

Many researchers in the UK will be forced to share lab space and basic equipment as the government there cuts funding for research, reports the Guardian's Ian Sample. Senior academics have said hard cuts to hardware and facilities budgets would "transform research in the UK," with some universities and centers hoarding equipment, leaving other researchers forced to scrounge for access to facilities and instruments, Sample says. UK Science Minister David Willetts recently said that the government would no longer fund four projects that have been highlighted as priorities by research councils, including a national supercomputing service to aid in drug development, for example. The Medical Research Council has asked scientists to be generous in sharing their equipment, Sample says. Researchers can now apply to research councils for only half the cost of lab equipment valued between £10,000 and £121,588, and in turn must acquire the rest of the funds they need from other sources, he adds. Many universities say their equipment is already being used to capacity by their own researchers, and that having to accommodate other projects will put pressure on researchers and delay their work, Sample adds.

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.